Article Text

Download PDFPDF
Selective Radiosensitization of Human Cervical Cancer Cells and Normal Cells by Artemisinin Through the Abrogation of Radiation-Induced G2 Block
  1. Xiao-mei Gong, MD*,
  2. Qing Zhang, MD,
  3. Artour Torossian, BS,
  4. Jian-ping Cao, MD, PhD§ and
  5. Shen Fu, MD, PhD
  1. *Department of Radiation Oncology, Shanghai Pulmonary Hospital of TongJi University, School of Medicine, Shanghai;
  2. Department of Radiation Oncology, The Sixth Hospital of Jiao Tong University, Shanghai, P.R. China;
  3. Vanderbilt University, School of Medicine, Nashville, TN; and
  4. §School of Radiation Medicine and Protection, Soochow University, Suzhou, P.R. China.
  1. Address correspondence and reprint requests to Shen Fu, MD, PhD, Department of Radiation Oncology, The Sixth Hospital of Jiao Tong University, 600 Yi Shan Rd, Shanghai 200233, PR China. E-mail: sjtusjtu2006@gmail.com.

Abstract

Objective Artemisinin has been shown to inhibit the growth of some human cancer cells. In this study, we investigated the radiosensitizing effects of artemisinin on cervical cancer cells and normal human fibroblast cells and also assessed some possible mechanisms for these effects.

Materials and Methods Two cervical cancer cell lines, HeLa and SiHa cells, and GM0639 normal human fibroblast cell line were treated with various concentrations of artemisinin plus radiation; the cell viability was tested using both 3-(4,5-dimethylthiazolyl-2-y1)-2, 5-diphenyltetrazolium bromide and clonogenic assays. Radiation dose-modifying factors were measured by clonogenic survival assay. Annexin V/propidium iodide assay for the evaluation of apoptosis and cell cycle phase were determined by flow cytometry, and the expression of the cell cycle–associated proteins Wee 1 and cyclin B1 were analyzed by Western blot analysis.

Results Artemisinin showed higher cytotoxicity in cervical cancer cell lines, especially in SiHa cells, than in the normal cell line. In both clonogenic assay and apoptosis, artemisinin sensitized the HeLa cancer cells to the cytotoxicity of radiation, yielding a dose-modifying factor of 1.24, but not SiHa cancer cells and GM normal cells. At a dose of 110 nmol/L, artemisinin did not change the distribution of cell cycle in 3 tested cell lines, but artemisinin abrogated the radiation-induced G2 blockade. Analyses of G2-checkpoint-related proteins, the activation of Wee 1 and depression of cyclin B1 expression induced by radiation, could be restored to the control level by artemisinin.

Conclusions Given the unique cytotoxic profile of artemisinin on cancer cells and normal cells, artemisinin may be a potentially promising radiosensitizer through the regulation of the expression of G2 checkpoint-related proteins like Wee 1 and cyclin B1, and improve therapeutic ratios for the combination of artemisinin and ionizing irradiation in the treatment of patients with cervical cancer.

  • Artemisinin
  • Cervical cancer cells
  • Normal fibroblast cells
  • Radiosensitization
  • Cell cycle

Statistics from Altmetric.com

Footnotes

  • Both Xiao-mei Gong, MD, and Qing Zhang, MD, contributed equally to this manuscript.

  • This article was funded by research grants (Grant No. 09JC411900, 09411951100) from the Science and Technology Commission of Shanghai and research grant (No. 81172597) from National Natural Science Fund, P.R. China.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.